Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment

Background: Metastatic colorectal cancer (mCRC) imposes a heavy tumor burden worldwide due to limited availability of therapeutic drugs. Aflibercept, a kind of recombinant protein of the anti-vascular endothelial growth factor (VEGF) family, has been approved in clinical application among mCRC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Pu, Wan, Ning, Han, Xiao, Wang, Xinpei, Zhang, Jinzi, Long, Xiaoyi, Wang, Xiaonan, Bian, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469875/
https://www.ncbi.nlm.nih.gov/pubmed/36110513
http://dx.doi.org/10.3389/fphar.2022.914683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469875/
https://www.ncbi.nlm.nih.gov/pubmed/36110513
http://dx.doi.org/10.3389/fphar.2022.914683

Ejemplares similares